Wir sind mit live! Mehr erfahren

Omada Health Inc

OMDA

Börsenwert 1,08 Mrd. $

17,63 USD

-1,04

5,57 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

17,80

+0,17

0,96 %

1 Tag

-5,57 %

5 Tage

-18,61 %

1 Monat

-10,78 %

3 Monate

-25,52 %

6 Monate

31,86 %

Seit Jahresbeginn

18,32 %

1 Jahr

-29,31 %

5 Jahre

-23,35 %

10 Jahre

-23,35 %

Profil: Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

Mitarbeiter: 946

Gesundheitswesen Gesundheitsinformationsdienste

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 37,5 %

Neutral 62,5 %

Negativ 0 %

Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026

SAN FRANCISCO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2026 results on Thursday, November 5, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at https://investors.omadahealth.com.

Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026

The Motley Fool

Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

The transaction represented 3% of the insider's direct equity holdings before the filing. The sale was conducted directly through an open-market transaction under a pre-established Rule 10b5-1 trading plan.

Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, will present its long-term financial targets at the company's inaugural Investor Day, being held today at the Four Seasons Hotel in New York, New York.

Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program

SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, announced a new, independent cost savings model that examined the measurable clinical and economic value of Omada's GLP-1 program.1 GlobalData , a data analytics and consulting company, recently published a report estimating greater disease reduction and higher cumulative cost savings with Omada's GLP-1 solutions compared to standard care.

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program

The Motley Fool

Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares

Traded 31,457 shares with a transaction value of ~$735,150 based on a weighted average price of $23.37 per share. The activity involved shares equal to 2% of the total equity stake held before the filing, including direct transactions equal to 8% of the prior direct position.

Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares

Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating. OMDA's product expansion, especially in diabetes and hypertension, is driving higher revenue per member and improving customer-lifetime-value through multi-program adoption. Channel partnerships with PBMs and health plans are lowering CAC, supporting scalable growth and better unit economics, while AI initiatives further enhance operational leverage.

Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Omada Health NASDAQ: OMDA highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen channel partnerships and use GLP-1-related demand to broaden customer relationships.

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Zacks Investment Research

Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt